Clinical Trial: A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07280936) titled 'A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses' on Dec. 01.

Brief Summary: This study is a randomized, double-blind, placebo-controlled, dose-escalation phase I clinical trial. This study consists of two parts: the single-dose escalation study (SAD) in healthy subjects and the multiple-dose escalation study (MAD) in obese patients.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: SHR-2906 Injection

SHR-2906 injection, in different doses.

DRUG: SHR-2906 Injection Placebo

SHR-2906 injection placebo....